RMTI Rockwell Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RMTI

Price (delayed)

$7.41

Market cap

$29.87M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.34

Enterprise value

$33.28M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 13

Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics ...

Highlights
RMTI's gross margin is up by 3.5% QoQ
The company's debt fell by 3.2% QoQ
The net income has shrunk by 142% YoY but it has increased by 6% QoQ
The EPS has plunged by 72% YoY but it has grown by 9% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.rockwellmed.com
Peers: ICUI BAX ABT NEPH

Key stats

What are the main financial stats of RMTI

RMTI stock price

How has the Rockwell Medical stock price performed over time
Intraday
-5.3%
1 week
3.78%
1 month
31.62%
1 year
-29.43%
YTD
-11.15%
QTD
34.48%

Financial performance

How have Rockwell Medical's revenue and profit performed over time
Revenue
$69.39M
Gross profit
$12.29M
Operating income
-$4.52M
Net income
-$5.08M
Gross margin
17.7%
Net margin
-7.3%
The net income has shrunk by 142% YoY but it has increased by 6% QoQ
Rockwell Medical's revenue has decreased by 21% YoY but it has increased by 2.5% from the previous quarter
The gross profit fell by 20% YoY but it rose by 6% QoQ
The company's net margin rose by 9% QoQ

Price vs fundamentals

How does RMTI's price correlate with its fundamentals

Growth

What is Rockwell Medical's growth rate over time

Valuation

What is Rockwell Medical stock price valuation
P/E
N/A
P/B
0.83
P/S
0.42
EV/EBIT
N/A
EV/EBITDA
190.17
EV/Sales
0.48
The EPS has plunged by 72% YoY but it has grown by 9% from the previous quarter
RMTI's price to book (P/B) is 70% lower than its 5-year quarterly average of 2.8 and 8% lower than its last 4 quarters average of 0.9
RMTI's equity is up by 15% year-on-year but it is down by 2.2% since the previous quarter
RMTI's price to sales (P/S) is 30% lower than its 5-year quarterly average of 0.6 and 16% lower than its last 4 quarters average of 0.5
Rockwell Medical's revenue has decreased by 21% YoY but it has increased by 2.5% from the previous quarter

Efficiency

How efficient is Rockwell Medical business performance
Rockwell Medical's return on assets has shrunk by 134% YoY but it has increased by 7% QoQ
RMTI's return on equity has dropped by 106% year-on-year but it is up by 9% since the previous quarter
The return on invested capital has increased by 11% since the previous quarter
The ROS has grown by 10% from the previous quarter

Dividends

What is RMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RMTI.

Financial health

How did Rockwell Medical financials performed over time
Rockwell Medical's total assets is 164% more than its total liabilities
RMTI's quick ratio is up by 22% YoY but it is down by 11% QoQ
RMTI's current ratio is down by 13% QoQ but it is up by 12% YoY
The company's debt is 60% lower than its equity
RMTI's equity is up by 15% year-on-year but it is down by 2.2% since the previous quarter
The debt to equity has contracted by 13% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.